FDA RELEASES TWO DISCUSSION PAPERS TO SPUR CONVERSATION ABOUT ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DEVELOPMENT AND MANUFACTURING

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): By: Patrizia Cavazzoni, M.D., Director of the Center for Drug Evaluation and Research [...]